JP Morgan Maintains Overweight on Cadre Hldgs, Lowers Price Target to $35
JP Morgan analyst Tomohiko Sano maintains Cadre Hldgs (NYSE:CDRE) with a Overweight and lowers the price target from $45 to $35.
Stocks · News reference
Cadre Holdings, Inc. has scheduled the release of its third quarter 2026 financial results and an accompanying conference call.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
JP Morgan analyst Tomohiko Sano maintains Cadre Hldgs (NYSE:CDRE) with a Overweight and lowers the price target from $45 to $35.
Defense stocks are on track for a seventh straight weekly loss, a first for XAR since 2011, as Iran peace talk and a stalled budget erase the 2026 gain.
Roth Capital analyst Matt Koranda reiterates Cadre Hldgs (NYSE:CDRE) with a Buy and raises the price target from $40 to $43.